Panostaja Oyj
Panostaja Oyj Managers' Transactions
Panostaja Oyj Stock Exchange Bulletin, Managers´ Transactions March 17, 2021 at 16:45 pm.
Person subject to the notification requirement | ||
Name: | Treindex Oy | Legal Person |
Position: | Member of the Board/Deputy member | |
Initial Notification | ||
Reference number: | 743700ZGH7GD27UOQO12_20210317142704_29 | |
Issuer | ||
Name: | Panostaja Oyj | |
LEI: | 743700ZGH7GD27UOQO12 | |
Transaction details | ||
Transaction date: | 2021-03-17 | |
Venue: | NASDAQ HELSINKI LTD (XHEL) | |
Nature of the transaction: | Acquisition | |
Instrument: | Share | |
ISIN: | FI0009800379 | |
Volume: | 1440000 | |
Unit price: | 0,70400 Euro | |
Aggregated transactions | ||
Volume: | 1440000 | |
Volume weighted average price: | 0.70400 Euro |
PANOSTAJA OYJ
For further information, contact CEO Tapio Tommila: tel. +358 (0)40-527 6311
www.panostaja.fi/en/
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
dsm-firmenich14.10.2025 07:00:12 CEST | Press release
Weekly progress on share repurchase program to cover share plans and reduce capital
Digital Check Corp.14.10.2025 06:01:00 CEST | Press release
Digital Check Introduces Next-Generation TellerScan® TS250 UV Ultraviolet Scanner
Mavenir Systems, Inc.14.10.2025 06:00:00 CEST | Press release
e& and Mavenir unveil AI-powered voice service security and anti-fraud collaboration
Biogen Inc.14.10.2025 01:30:00 CEST | Press release
LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME’s “Best Inventions of 2025”
Bombardier Inc.13.10.2025 22:02:56 CEST | Press release
Bombardier Global 8000, The World’s Fastest Business Jet, Gets Even Faster with a New Top Speed of Mach 0.95
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom